Report on Sweden's capacity to produce vaccines

Vinnova has been commissioned by the government to, in collaboration with RISE Research Institutes of Sweden, the Inquiry into access to vaccines against covid-19 and the Inquiry into health care preparedness, analyze Sweden's innovation and production capacity for vaccines and other biological drugs.

The report submitted is a knowledge base. It states that Sweden has several companies that are active in different parts of the production chain and that improved production capacity and strengthened innovation environments focused on process development and production of vaccines and biological drugs in the long run can increase the opportunities to contribute to the growing need for vaccines in Sweden and the world. Such investments can also contribute to the development of new products and new companies in the area.

Sweden's opportunities to be completely self-sufficient in vaccines are, however, considered small, as it is a complex production that is dependent on international suppliers of raw materials, equipment and materials.

With regard to the ongoing pandemic, it is stated that a strong European partnership with open trade borders provides the best conditions for securing access to vaccines for Sweden.